+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Large Molecule Injectable Drugs Market 2023-2027 - Product Thumbnail Image

Large Molecule Injectable Drugs Market 2023-2027

  • Report
  • July 2023
  • 158 Pages
  • Global
From
From
Interferons Market 2024-2028 - Product Thumbnail Image

Interferons Market 2024-2028

  • Report
  • March 2024
  • 160 Pages
  • Global
From
From
From
Regenerative Medicine Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Regenerative Medicine Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 139 Pages
  • Global
From
Sjogrens Syndrome Therapeutics Market 2024-2028 - Product Thumbnail Image

Sjogrens Syndrome Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 160 Pages
  • Global
From
Industry Snapshots: US Biotechnology - Product Thumbnail Image

Industry Snapshots: US Biotechnology

  • Newsletter
  • November 2024
  • 50 Pages
  • United States
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 409 Pages
  • Global
From
From
Addisons Disease Therapeutics Market 2024-2028 - Product Thumbnail Image

Addisons Disease Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 166 Pages
  • Global
From
From
From
Loading Indicator